Nextvestment provides financial guidance co-pilot software for Phillip Securities’ trading platform’s AI capability

Nextvestment today shared about their provision of financial guidance co-pilot software for Phillip Securities' trading platform's AI capability, POEMSGPT. The project marks a major step toward making AI-powered investing accessible to everyday traders. https://mma.prnewswire.com/media/2821296/Nextvestment___PR.jpg POEMSGPT demonstrates how established financial institutions and emerging AI innovators can collaborate to shape the future of investor engagement and reinforce […]

PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering GlobeNewswire November 12, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. – PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce

American Banker names Washington Trust one of the best banks to work for in the U.S.

Washington Trust is one of only 90 banks nationwide to earn this designation in 2025 American Banker magazine has named Washington Trust to its 2025 list of the Best Banks to Work For – an exclusive group of only 90 banks in the United States that excel at creating positive and supportive workplaces for employees.

Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®

Acquiring the Canadian rights toLEVULAN KERASTICK (aminolevulinic acid hydrochloride) further expands the Sun Pharma Canada dermatology portfolio and reinforces the company's commitment to patient care. Sun Pharma, a global pharmaceutical company with a growing portfolio of Innovative Medicines, today announced it acquired, at no cost, the commercial sales rights to LEVULAN KERASTICK (aminolevulinic acid hydrochloride)

/C O R R E C T I O N — The Hershey Company/

In the news release, Holiday Magic and Savings! Arrive at HERSHEY'S CHOCOLATE WORLD with a Ride Makeover and New Holiday Bundle, issued 12-Nov-2025 by The Hershey Company over PR Newswire, we are advised by the company that the second bullet under the “Toffee Truffle Inspired Treats” section should read “…and a HERSHEY'S Toffee Truffle” rather

Ecopetrol Announces Changes in Senior Management

Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) announces that the Board of Directors appointed the following leadership positions, during its meeting on November 11, 2025, all of which will be effective as of November 16: https://mma.prnewswire.com/media/2321203/ecopetrol_s_a__logo_Logo.jpg Juan Carlos Hurtado Parra as Executive Vice President of Hydrocarbons.Mr. Hurtado, who previously served as Vice President of Exploration, Development,

Spherix Global Insights Reveals Unmet Need Driving Interest in Emerging Therapies for Thyroid Eye Disease

Exton, PA, Nov. 12, 2025 (GLOBE NEWSWIRE) — New research from Spherix Global Insights finds that while Amgen's Tepezza (teprotumumab) continues to anchor the treatment landscape for thyroid eye disease (TED), physicians emphasize ongoing unmet needs–particularly for patients with milder disease, contraindications to treatment, or limited access. Findings from Market Dynamix(TM): Thyroid Eye Disease (US)

Expanding Board of Directors at The HOW Institute for Society Signals Growing Commitment to Answer Demand for Values-based Behavior Across Sectors

Among those joining the board in 2025 are Jon Huntsman, General (ret.) Dave Goldfein, Dr. Wayne A.I. Frederick, Devika Bulchandani, and Amy Rosen The HOW Institute for Society welcomed five new board members this year as the work of the institute ramps up in new sectors to address the demand for values-based behavior and principled

Spherix Global Insights Reveals Unmet Need Driving Interest in Emerging Therapies for Thyroid Eye Disease

Spherix Global Insights Reveals Unmet Need Driving Interest in Emerging Therapies for Thyroid Eye Disease Physicians highlight early intervention, safety, and access limitations as key unmet needs–Tepezza SC anticipated to reshape the treatment paradigm in 2026 GlobeNewswire November 12, 2025 Exton, PA, Nov. 12, 2025 (GLOBE NEWSWIRE) — New research from Spherix Global Insights finds

Scroll to Top